![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KSR1 |
Gene summary for KSR1 |
![]() |
Gene information | Species | Human | Gene symbol | KSR1 | Gene ID | 8844 |
Gene name | kinase suppressor of ras 1 | |
Gene Alias | KSR | |
Cytomap | 17q11.2 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q8IVT5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8844 | KSR1 | P8T-E | Human | Esophagus | ESCC | 3.97e-05 | 1.23e-01 | 0.0889 |
8844 | KSR1 | P9T-E | Human | Esophagus | ESCC | 6.21e-03 | 5.15e-02 | 0.1131 |
8844 | KSR1 | P10T-E | Human | Esophagus | ESCC | 4.10e-02 | 2.31e-02 | 0.116 |
8844 | KSR1 | P23T-E | Human | Esophagus | ESCC | 1.19e-03 | 1.20e-01 | 0.108 |
8844 | KSR1 | P26T-E | Human | Esophagus | ESCC | 4.15e-03 | 7.88e-02 | 0.1276 |
8844 | KSR1 | P27T-E | Human | Esophagus | ESCC | 2.42e-04 | 9.64e-02 | 0.1055 |
8844 | KSR1 | P28T-E | Human | Esophagus | ESCC | 2.29e-08 | 2.21e-01 | 0.1149 |
8844 | KSR1 | P36T-E | Human | Esophagus | ESCC | 7.55e-04 | 1.77e-01 | 0.1187 |
8844 | KSR1 | P39T-E | Human | Esophagus | ESCC | 4.12e-06 | 7.34e-02 | 0.0894 |
8844 | KSR1 | P42T-E | Human | Esophagus | ESCC | 3.51e-06 | 1.05e-01 | 0.1175 |
8844 | KSR1 | P44T-E | Human | Esophagus | ESCC | 1.10e-02 | 7.23e-02 | 0.1096 |
8844 | KSR1 | P54T-E | Human | Esophagus | ESCC | 4.79e-13 | 3.55e-01 | 0.0975 |
8844 | KSR1 | P61T-E | Human | Esophagus | ESCC | 1.50e-02 | 1.17e-01 | 0.099 |
8844 | KSR1 | P82T-E | Human | Esophagus | ESCC | 1.96e-04 | 2.23e-01 | 0.1072 |
8844 | KSR1 | P107T-E | Human | Esophagus | ESCC | 7.03e-03 | 1.37e-01 | 0.171 |
8844 | KSR1 | P127T-E | Human | Esophagus | ESCC | 5.45e-06 | 1.34e-01 | 0.0826 |
8844 | KSR1 | P128T-E | Human | Esophagus | ESCC | 2.34e-12 | 5.81e-01 | 0.1241 |
8844 | KSR1 | P130T-E | Human | Esophagus | ESCC | 3.18e-24 | 5.74e-01 | 0.1676 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007265 | Colorectum | AD | Ras protein signal transduction | 104/3918 | 337/18723 | 1.01e-05 | 2.35e-04 | 104 |
GO:0007266 | Colorectum | AD | Rho protein signal transduction | 42/3918 | 137/18723 | 4.64e-03 | 3.16e-02 | 42 |
GO:00072651 | Colorectum | MSS | Ras protein signal transduction | 91/3467 | 337/18723 | 7.20e-05 | 1.21e-03 | 91 |
GO:007190016 | Esophagus | ESCC | regulation of protein serine/threonine kinase activity | 227/8552 | 359/18723 | 1.12e-11 | 4.10e-10 | 227 |
GO:000726510 | Esophagus | ESCC | Ras protein signal transduction | 201/8552 | 337/18723 | 1.44e-07 | 2.30e-06 | 201 |
GO:00434055 | Esophagus | ESCC | regulation of MAP kinase activity | 102/8552 | 177/18723 | 8.89e-04 | 4.55e-03 | 102 |
GO:000726610 | Esophagus | ESCC | Rho protein signal transduction | 81/8552 | 137/18723 | 1.03e-03 | 5.20e-03 | 81 |
GO:00072659 | Oral cavity | OSCC | Ras protein signal transduction | 185/7305 | 337/18723 | 1.95e-09 | 4.60e-08 | 185 |
GO:00072669 | Oral cavity | OSCC | Rho protein signal transduction | 76/7305 | 137/18723 | 6.64e-05 | 5.37e-04 | 76 |
GO:000726515 | Oral cavity | LP | Ras protein signal transduction | 109/4623 | 337/18723 | 8.44e-04 | 7.36e-03 | 109 |
GO:000726516 | Skin | AK | Ras protein signal transduction | 68/1910 | 337/18723 | 2.83e-08 | 1.57e-06 | 68 |
GO:000726616 | Skin | AK | Rho protein signal transduction | 31/1910 | 137/18723 | 1.60e-05 | 3.09e-04 | 31 |
GO:000726523 | Skin | cSCC | Ras protein signal transduction | 132/4864 | 337/18723 | 6.17e-08 | 1.57e-06 | 132 |
GO:000726617 | Skin | cSCC | Rho protein signal transduction | 51/4864 | 137/18723 | 2.38e-03 | 1.38e-02 | 51 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa046259 | Esophagus | ESCC | C-type lectin receptor signaling pathway | 73/4205 | 104/8465 | 1.57e-05 | 7.98e-05 | 4.09e-05 | 73 |
hsa051527 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
hsa0462513 | Esophagus | ESCC | C-type lectin receptor signaling pathway | 73/4205 | 104/8465 | 1.57e-05 | 7.98e-05 | 4.09e-05 | 73 |
hsa0515212 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KSR1 | deletion | Frame_Shift_Del | rs763290558 | c.461delC | p.Pro154HisfsTer36 | p.P154Hfs*36 | Q8IVT5 | protein_coding | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KSR1 | deletion | Frame_Shift_Del | rs763290558 | c.454delN | p.Pro154HisfsTer36 | p.P154Hfs*36 | Q8IVT5 | protein_coding | TCGA-AP-A1DM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
KSR1 | insertion | Frame_Shift_Ins | rs750491454 | c.461dupC | p.Pro155ThrfsTer22 | p.P155Tfs*22 | Q8IVT5 | protein_coding | TCGA-AX-A2HG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
KSR1 | insertion | Frame_Shift_Ins | rs750491454 | c.453_454insC | p.Pro155ThrfsTer22 | p.P155Tfs*22 | Q8IVT5 | protein_coding | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
KSR1 | deletion | Frame_Shift_Del | rs763290558 | c.461delC | p.Pro154HisfsTer36 | p.P154Hfs*36 | Q8IVT5 | protein_coding | TCGA-AX-A3G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KSR1 | insertion | Frame_Shift_Ins | rs750491454 | c.461dupC | p.Pro155ThrfsTer22 | p.P155Tfs*22 | Q8IVT5 | protein_coding | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | ||
KSR1 | insertion | Frame_Shift_Ins | rs750491454 | c.453_454insC | p.Pro155ThrfsTer22 | p.P155Tfs*22 | Q8IVT5 | protein_coding | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
KSR1 | deletion | Frame_Shift_Del | rs763290558 | c.454delN | p.Pro154HisfsTer36 | p.P154Hfs*36 | Q8IVT5 | protein_coding | TCGA-D1-A2G0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KSR1 | deletion | Frame_Shift_Del | rs763290558 | c.454delN | p.Pro154HisfsTer36 | p.P154Hfs*36 | Q8IVT5 | protein_coding | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD | ||
KSR1 | insertion | Frame_Shift_Ins | rs750491454 | c.461dupC | p.Pro155ThrfsTer22 | p.P155Tfs*22 | Q8IVT5 | protein_coding | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |